Pharmacotherapy of Alzheimer's disease;Farmakoterapija Alzheimerove bolesti

Medicus

Volumn 11, Issue 2, 2002, Pages 217-222

  Folnegović Šmalc, Vera ^a   Uzun, Suzana ^a   Kozumplik, Oliver ^a   Folnegović Grošić, Petra ^b   Henigsberg, Neven ^a   Makarić, Gordan ^a   Mihanović, Mato ^c   Mimica, Ninoslav ^a  

^a University of Zagreb   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c Sisak I Psihijatrijska Bolnica Sveti Ivan   (Croatia)

Author keywords

Alzheimer's disease; Dementia; Pharmacotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; HYPNOTIC SEDATIVE AGENT; METRIFONATE; NEUROLEPTIC AGENT; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

AGED; AGITATION; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CAREGIVER; CLINICAL EXAMINATION; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; FAMILY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MEMORY DISORDER; NEUROPATHOLOGY; NEUROPSYCHOLOGY; PREVALENCE; RATING SCALE; SIDE EFFECT; VERTIGO;

EID: 0036958844     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GAUTHIER S. Clinical diagnosis and management of Alzheimer's disease. London: Martin Dunitz Ltd, 1996.
2. HEYMAN A, WILKINSON WE, STAFFORD JA, HELMS MJ, SIGMON AH, WEINBERG T. Alzheimer's disease: a study of epidemiological aspects. Annals of Neurology 1984; 15: 335-41.
3. FOLNEGOVIĆ-ŠMALC V, FOLNEGOVIĆ Z, UZUN S, VILIBIĆ M, DUJMIĆ S, MAKARIĆ G. Psychotrauma Related to War and Exile as a Risk Factor for the Development of Dementia of Alzheimer's Type in Refugees. Croat Med J 1997; 38(3):273-6.
4. LISHMAN WA. Organic psychiatry. The Psychological consequences of cerebral disorder. Third edition. London: Blackwell Science Ltd, 1999.
5. BLESSED G. Biochemistry of dementia. Chicester: Roberts PJ, John Wiley, 1980.
6. COREY-BLOOM J, THAL LJ, GALASKO D et al. Diagnosis and evaluation of dementia. Neurology 1995; 45: 211-8.
7. HESTON LL, MASTRI AR, ANDERSON E, WHITE J. Dementia of the Alzheimer type. Clinical genetics, natural history and associated conditions. Archives of General Psychiatry 1981; 38: 1085-90
8. BABIĆ T, FOLNEGOVIĆ-ŠMALC V, HENIGSBERG N. Racionalna dijagnostika i liječenje Alzheimerove bolesti. Neurol Croat 1999; 48(1):61-6.
9. Medunarodna klasifikacija bolesti i srodnih stanja (MKB-10). Zagreb: Medicinska naklada, 1994.
10. Američka psihijatrijska udruga. Dijagnostički i statistički priručnik duševnih poremećaja, DSM-IV, Jastrebarsko: Naklada Slap, 1996.
11. JACOBS DM, SANO M, DOONEIEF G, MARDER K, BELL KL, STERN Y. Neuropsychological detection and characterization of preclinical Alzheimer's desease. Neurology 1995; 45: 957-62.
12. FOLSTEIN MF, FOLSTEIN SE, McHUGH PR. Mini mental state. A practical method for grading the cognitive state of patients for the children. Journal of psychiatric research 1975; 12: 189-98.
13. MIMICA N, UZUN S, FOLNEGOVIĆ-ŠMALC V. Mjerni instrument u demenciji. Treći hrvatski psihijatrijski kongres, Sažeci radova, Osijek, 25.-28. rujna, 2002: 118-9.
14. DUDAI Y. The neurobiology of memory. Concepts, findings, trends. New York: Oxford Universitry Press, 1989.
15. UZUN S, MIMICA N, FOLNEGOVIĆ-ŠMALC V. Suvremena farmakoterapija demencija. Treći hrvatski psihijatrijski kongres, Sažeci radova, Osijek, 25-28. rujna, 2002: 118.
16. McCONNELL H, DUFFY J. Geriatric Neuropsychiatry. Washington DC: American Psychiatric Press, 1994.
17. McCONNELL H, SNYDER PJ. Handbook of Neuropsychology and Aging. New York: Plenum Press, 1998.
18. NEWCOMER JW, FARBER NB, OLNEY, JW. NMDA receptor function, memory, and brain aging. Dialogues in clinical neuroscience 2000; 2(3):219-32.
19. PENDLEBURY WW, SOLOMON PR. Alzheimer's Disease in Clinical Symposia 1996; 48(3).
20. STREET JS, CLARK WS, GANNON KS et al. Olanzapine treatment of psychotic and behavioral symptoms in Alzheimer Disease. Archives of General Psychiatry 2000; 57: 968-76.